investorscraft@gmail.com

Intrinsic value of RadNet, Inc. (RDNT)

Previous Close$20.70
Intrinsic Value
Upside potential
Previous Close
$20.70
Use floor (the cash flow based valuation has rendered a result, which is lower than an estimated minimum value derived from the company’s balance sheet analysis)

VALUATION INPUT DATA (original, your and others' valuations)

ParameterOrig.Your
Date of valuation (DoV)  
Intrinsic value (IV) at DoV, $/sh  
IV at current val. algorithm, $/sh21.8 

The original valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-03-31.

Registered users can save their valuation input data

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.

Company description

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems; and provides teleradiology services for remote interpretation of images on behalf of hospitals and hospital-based radiology groups. As of December 31, 2019, it operated 335 centers in California, Delaware, Florida, Maryland, New Jersey, and New York. RadNet, Inc. has a collaboration with Hologic, Inc. to advance the use of artificial intelligence in breast health. The company was founded in 1985 and is headquartered in Los Angeles, California.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2021(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %22.7NaN
Revenue, $1315NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m1232NaN
Operating income, $m83NaN
EBITDA, $m253NaN
Interest expense (income), $mNaN
Earnings before tax, $m40NaN
Tax expense, $m15NaN
Net income, $m25NaN

BALANCE SHEET

Cash and short-term investments, $m135NaN
Total assets, $m2254NaN
Adjusted assets (=assets-cash), $m2119NaN
Average production assets, $m1524NaN
Working capital, $m-51NaN
Total debt, $m1398NaN
Total liabilities, $m2025NaN
Total equity, $m229NaN
Debt-to-equity ratio6.105NaN
Adjusted equity ratio0.081NaN

CASH FLOW

Net income, $m25NaN
Depreciation, amort., depletion, $m171NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m222NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-137NaN
Free cash flow, $m359NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m-51
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount